News Conference News ACC 2024 Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6 Yael L. Maxwell April 08, 2024
News Conference News ACC 2024 ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI Yael L. Maxwell April 07, 2024
News Conference News ACC 2024 Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI Michael O'Riordan April 07, 2024
News Conference News EHRA 2024 Secondhand Smoke Tied to Higher Risk of Incident AF Todd Neale April 07, 2024
News Conference News ACC 2024 Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI Shelley Wood April 06, 2024
News Daily News Climbing Everest? Cardiac Arrhythmias Join Other Fabled Risks Michael O'Riordan April 04, 2024
News Conference News ACC 2024 Faster CAC Progression After Menopause May Warrant Intensified Therapy L.A. McKeown April 04, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2024 Shelley Wood April 03, 2024
News Conference News ACC 2024 Lack of Sleep Ups Hypertension Risk, Especially for Women Yael L. Maxwell April 03, 2024
News Conference News ACC 2024 Heavy Drinking May Contribute to CHD Risk in Young Women L.A. McKeown April 02, 2024
News Conference News ACC 2024 ADHD Meds Linked to Cardiomyopathy in Young Adults Todd Neale April 01, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News Biologic Winrevair Wins FDA Approval for Treatment of PAH L.A. McKeown March 27, 2024
News Conference News Lifestyle Changes Can Curb CVD Risk After Adverse Pregnancy Outcomes Yael L. Maxwell March 26, 2024
News Daily News ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain Todd Neale March 25, 2024
News Conference News Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality Michael O'Riordan March 22, 2024
News Daily News When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters Yael L. Maxwell March 21, 2024